|
Brief Reports
Citations 101-110 of 1234 total displayed.
|
Past content
(since Jul 1999):
|
Deficiency of von Willebrand factor protects mice from ischemic stroke
- Christoph Kleinschnitz, Simon F. De Meyer, Tobias Schwarz, Madeleine Austinat, Karen Vanhoorelbeke, Bernhard Nieswandt, Hans Deckmyn, and Guido Stoll
Blood 2009; 113: 3600-3603.
[Abstract]
[Full text]
[PDF]
Relevance of the immunoglobulin VH somatic mutation status in patients with chronic lymphocytic leukemia treated with fludarabine, cyclophosphamide, and rituximab (FCR) or related chemoimmunotherapy regimens
- Katherine I. Lin, Constantine S. Tam, Michael J. Keating, William G. Wierda, Susan O'Brien, Susan Lerner, Kevin R. Coombes, Ellen Schlette, Alessandra Ferrajoli, Lynn L. Barron, Thomas J. Kipps, Laura Rassenti, Stefan Faderl, Hagop Kantarjian, and Lynne V. Abruzzo
Blood 2009; 113: 3168-3171.
[Abstract]
[Full text]
[PDF]
Molecular mimicry of host sialylated glycans allows a bacterial pathogen to engage neutrophil Siglec-9 and dampen the innate immune response
- Aaron F. Carlin, Satoshi Uchiyama, Yung-Chi Chang, Amanda L. Lewis, Victor Nizet, and Ajit Varki
Blood 2009; 113: 3333-3336.
[Abstract]
[Full text]
[PDF]
The Montreal platelet syndrome kindred has type 2B von Willebrand disease with the VWF V1316M mutation
- Shannon C. Jackson, Gary D. Sinclair, Stephanie Cloutier, Zhaoxia Duan, Margaret L. Rand, and Man-Chiu Poon
Blood 2009; 113: 3348-3351.
[Abstract]
[Full text]
[PDF]
Role of activated protein C and its receptor in inhibition of tumor metastasis
- Michael Bezuhly, Robyn Cullen, Charles T. Esmon, Steven F. Morris, Kenneth A. West, Brent Johnston, and Robert S. Liwski
Blood 2009; 113: 3371-3374.
[Abstract]
[Full text]
[PDF]
Prolonged survival in adults with acute lymphoblastic leukemia after reduced-intensity conditioning with cord blood or sibling donor transplantation
- Veronika Bachanova, Michael R. Verneris, Todd DeFor, Claudio G. Brunstein, and Daniel J. Weisdorf
Blood 2009; 113: 2902-2905.
[Abstract]
[Full text]
[PDF]
FAS-L, IL-10, and double-negative CD4–CD8– TCR  /β+ T cells are reliable markers of autoimmune lymphoproliferative syndrome (ALPS) associated with FAS loss of function
- Aude Magerus-Chatinet, Marie-Claude Stolzenberg, Maria S. Loffredo, Bénédicte Neven, Catherine Schaffner, Nicolas Ducrot, Peter D. Arkwright, Brigitte Bader-Meunier, José Barbot, Stéphane Blanche, Jean-Laurent Casanova, Marianne Debré, Alina Ferster, Claire Fieschi, Benoit Florkin, Claire Galambrun, Olivier Hermine, Olivier Lambotte, Eric Solary, Caroline Thomas, Francoise Le Deist, Capucine Picard, Alain Fischer, and Frédéric Rieux-Laucat
Blood 2009; 113: 3027-3030.
[Abstract]
[Full text]
[PDF]
Double CEBPA mutations, but not single CEBPA mutations, define a subgroup of acute myeloid leukemia with a distinctive gene expression profile that is uniquely associated with a favorable outcome
- Bas J. Wouters, Bob Löwenberg, Claudia A. J. Erpelinck-Verschueren, Wim L. J. van Putten, Peter J. M. Valk, and Ruud Delwel
Blood 2009; 113: 3088-3091.
[Abstract]
[Full text]
[PDF]
Caspase-7 deficiency protects from endotoxin-induced lymphocyte apoptosis and improves survival
- Mohamed Lamkanfi, Lilian O. Moreira, Patrudu Makena, Diana C. J. Spierings, Kelli Boyd, Peter J. Murray, Douglas R. Green, and Thirumala-Devi Kanneganti
Blood 2009; 113: 2742-2745.
[Abstract]
[Full text]
[PDF]
PKCβ is essential for the development of chronic lymphocytic leukemia in the TCL1 transgenic mouse model: validation of PKCβ as a therapeutic target in chronic lymphocytic leukemia
- Claudia Holler, Josefina D. Piñón, Ursula Denk, Christoph Heyder, Sebastian Hofbauer, Richard Greil, and Alexander Egle
Blood 2009; 113: 2791-2794.
[Abstract]
[Full text]
[PDF]
|
|
